ADVERSE EVENT REPORTING PROCEDURES. The Parties hereby agree that the following terms will govern disclosures of each Party to the other with respect to adverse event reporting relating to the Product as clinically tested or marketed by or on behalf of either Party.
Appears in 8 contracts
Samples: Exclusive License and Supply Agreement (Icn Pharmaceuticals Inc), Exclusive License and Supply Agreement (Icn Pharmaceuticals Inc), Exclusive License and Supply Agreement (Icn Pharmaceuticals Inc)
ADVERSE EVENT REPORTING PROCEDURES. The Parties hereby agree that the following terms will govern disclosures of each Party to the other with respect to adverse event reporting relating to the any R&D Candidate or Product as clinically tested or marketed by or on behalf of either Party.
Appears in 1 contract
ADVERSE EVENT REPORTING PROCEDURES. The Parties hereby agree that the following terms will govern disclosures of each Party to the other with respect to adverse event reporting relating to the any Development Candidate or Product as clinically tested or marketed by or on behalf of either Party.
Appears in 1 contract
Samples: Collaboration and License Agreement (Viropharma Inc)